Pharmablock Sciences Nanjing Co., Ltd. (300725)
Market Closed
10 Aug, 06:57
XSHE XSHE Primary ¥
49. 61
+2.11
+4.4421%
¥
8.98B Market Cap
- P/E Ratio
1.12% Div Yield
54.05M Volume
- Eps
¥ 47.5
Previous Close Want to track 300725 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
300725 closed yesterday higher at ¥49.61, an increase of 4.4421% from Friday's close, completing a monthly increase of 37.5% or ¥13.53. Over the past 12 months, 300725 stock gained 28.5233%.
300725 pays dividends to its shareholders, with the most recent payment made on Jun 10, 2026. The next estimated payment will be in In 9 months on Jun 10, 2027 for a total of ¥0.28.
The last earnings report, released on Apr 22, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.129%, based on the last three reports.
Pharmablock Sciences Nanjing Co., Ltd. has completed 3 stock splits, with the recent split occurring on Apr 26, 2021.
The company's stock is traded on one exchange.
Pharmablock Sciences Nanjing Co., Ltd. (300725) FAQ
What is the stock price today?
The current price is ¥49.61.
On which exchange is it traded?
Pharmablock Sciences Nanjing Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 300725.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 1.12%.
What is its market cap?
As of today, the market cap is 8.98B.
Has Pharmablock Sciences Nanjing Co., Ltd. ever had a stock split?
Pharmablock Sciences Nanjing Co., Ltd. had 3 splits and the recent split was on Apr 26, 2021.
Pharmablock Sciences Nanjing Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Dr. Minmin Yang Ph.D. CEO | XSHE Exchange | CNE1000035K5 ISIN |
| CN Country | - Employees | 10 Jun 2026 Last Dividend | 8 May 2019 Last Split | - IPO Date |
Overview
PharmaBlock Sciences (Nanjing), Inc. is a distinguished provider in the realm of chemistry products and services, catering to the pharmaceutical industry's diverse needs across research and development (R&D), as well as commercial production. Since its establishment in 2006, PharmaBlock has been committed to supporting the pharmaceutical community's evolving demands by delivering high-quality, tailored solutions. Headquartered in Nanjing, the People's Republic of China, the company has built a robust reputation for its extensive portfolio of products and adept services that streamline the drug development lifecycle, from discovery through to commercialization.
Products and Services
PharmaBlock's offerings are meticulously designed to meet the comprehensive requirements of the pharmaceutical industry, focusing on efficiency and innovation.
- Building Blocks Collection: A vast array of chemical building blocks essential for drug discovery and development. These specialized molecules are designed for high versatility and reactivity, facilitating the creation of complex compounds.
- Supplying from Discovery, Development to Commercial: An integrated supply chain solution that supports pharmaceutical companies at each phase of drug development. This service ensures a seamless transition from initial discovery through to commercial-scale production, offering both scalability and reliability.
- Building Blocks Driven Libraries for Drug Discovery: Tailored libraries of compounds derived from PharmaBlock’s comprehensive collection of building blocks. These libraries are crucial for high-throughput screening processes in drug discovery, offering diverse chemical entities to expedite the identification of active compounds.
- Development and Manufacturing of RSMs, Intermediates, APIs, and Drug Products: Custom development and manufacturing services for key drug components, including raw starting materials (RSMs), intermediates, active pharmaceutical ingredients (APIs), and finalized drug products. These offerings are designed to meet the stringent quality and regulatory requirements of the pharmaceutical industry, ensuring the provision of safe and effective medicines.
Contact Information
Address: No. 81, Huasheng Road, Nanjing, China, 210032
Phone: 86 25 8691 8218
Website: https://www.pharmablock.com
